Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

3.4.23.15: renin

This is an abbreviated version!
For detailed information about renin, go to the full flat file.

Word Map on EC 3.4.23.15

Reaction

cleavage of Leu-/- bond in angiotensinogen to generate angiotensin I =

Synonyms

angiotensin-forming enzyme, angiotensinogenase, EC 3.4.4.15, EC 3.4.99.19, prorenin, REN, SVAP, SVAP A1, SVAP B1, SVAP B2, venom aspartic protease

ECTree

     3 Hydrolases
         3.4 Acting on peptide bonds (peptidases)
             3.4.23 Aspartic endopeptidases
                3.4.23.15 renin

Expression

Expression on EC 3.4.23.15 - renin

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EXPRESSION
ORGANISM
UNIPROT
LITERATURE
20 mg furosemide induces activation of renin
-
after 5 weeks of renal artery stenosis, plasma renin activity is 3fold greater than in sham-operated rabbits
-
angiotensin II inhibits renin release from the juxtaglomerular cells in the kidney
-
angiotensin II inhibits the release of renin from the kidney
-
chronic sympatho-inhibition with rilmenidine (2.5 mg/kg/day) reduces basal plasma renin activity
-
diuretics increase plasma renin concentration and plasma renin activity, as volume depletion stimulates the release of renin from the kidney
-
renin inhibitors like aliskiren increase the plasma concentration of renin because they attenuate the negative feedback effect of angiotensin II on renin release
-
renin release from juxtaglomerular cells is inhibited by Ca2+ and calcium-dependent phosphodiesterase 1C
-
renin release from juxtaglomerular cells is stimulated by cAMP
-
renin-angiotensin-aldosterone system blockade with angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers leads to exacerbated renin release through loss of negative-feedback inhibition
-
the angiotensin type I receptor 1166C allele in homozygous form is characterized by low plasma renin levels
-
the enzyme exhibits low mRNA expression levels in all stages of pre-adipocyte differentiation with no significant transcriptional increase up to day 21
-
there are no significant differences in mRNA abundance between salinities or time for the enzyme gene
-
there is an increase of renin activity in the kidney of TGM(rTon) mice when compared to control animals
-
treatment with 0.05 mg urocortin 2 or 0.05 mg urocortin 2 plus 20 mg furosemide markedly reduces plasma renin activity
-
treatment with 16 mg azelnidipine for 4 weeks does not affect plasma renin activity
-
tubular renin protein is increased by angiotensin II (400 ng/kg/min infusion for 12 days) and angiotensin-converting enzyme inhibitor (lisinopril, 100 mg/l), but not by the combination of angiotensin II plus angiotensin-converting enzyme inhibitor
-